| scholarly article | Q13442814 |
| P50 | author | Adam C. Siepel | Q4678820 |
| Joshua J Waterfall | Q37380392 | ||
| P2093 | author name string | John T Lis | |
| Charles G Danko | |||
| W Lee Kraus | |||
| Nasun Hah | |||
| Leighton Core | |||
| P2860 | cites work | Genomic analyses of hormone signaling and gene regulation | Q37690710 |
| Biochemical analyses of nuclear receptor-dependent transcription with chromatin templates | Q37726327 | ||
| Regulation of estrogen receptor-mediated long range transcription via evolutionarily conserved distal response elements | Q39947046 | ||
| Synchronous and stochastic patterns of gene activation in the Drosophila embryo | Q42100396 | ||
| Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype | Q44576030 | ||
| Targeted 3' processing of antisense transcripts triggers Arabidopsis FLC chromatin silencing | Q51920988 | ||
| Accumulation of heat shock protein 70 RNA and its relationship to protein synthesis after heat shock in mammalian cells | Q69720724 | ||
| Discovery of estrogen receptor alpha target genes and response elements in breast tumor cells | Q21184176 | ||
| MicroRNA targeting specificity in mammals: determinants beyond seed pairing | Q24607724 | ||
| Estrogen receptors and human disease | Q24645374 | ||
| Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets | Q27860792 | ||
| edgeR: a Bioconductor package for differential expression analysis of digital gene expression data | Q27860819 | ||
| The widespread regulation of microRNA biogenesis, function and decay | Q28131796 | ||
| Promoter-associated pausing in promoter architecture and postinitiation transcriptional regulation | Q28138307 | ||
| SOAP2: an improved ultrafast tool for short read alignment | Q28247469 | ||
| Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1 | Q28260929 | ||
| Nascent RNA sequencing reveals widespread pausing and divergent initiation at human promoters | Q28302903 | ||
| Selenocysteine | Q29409802 | ||
| An oestrogen-receptor-α-bound human chromatin interactome | Q29541719 | ||
| The widespread impact of mammalian MicroRNAs on mRNA repression and evolution | Q29547173 | ||
| Antisense transcription in the mammalian transcriptome | Q29547536 | ||
| Widespread transcription at neuronal activity-regulated enhancers | Q29614330 | ||
| Divergent transcription from active promoters | Q29614332 | ||
| Genome-wide analysis of estrogen receptor binding sites | Q29614765 | ||
| GOstat: find statistically overrepresented Gene Ontologies within a group of genes | Q29618721 | ||
| Bidirectional transcription directs both transcriptional gene activation and suppression in human cells | Q33384427 | ||
| BioMart Central Portal--unified access to biological data | Q33440110 | ||
| Identification of gene co-regulatory modules and associated cis-elements involved in degenerative heart disease | Q33454995 | ||
| The estrogen receptor family. | Q33658841 | ||
| Estrogen receptor action in three dimensions - looping the loop | Q33892889 | ||
| Transcriptional activation by nuclear receptors | Q35830313 | ||
| A global view of transcriptional regulation by nuclear receptors: gene expression, factor localization, and DNA sequence analysis | Q37095266 | ||
| Postrecruitment regulation of RNA polymerase II directs rapid signaling responses at the promoters of estrogen target genes | Q37099958 | ||
| ChIP-Seq of ERalpha and RNA polymerase II defines genes differentially responding to ligands | Q37207706 | ||
| What do natural antisense transcripts regulate? | Q37355554 | ||
| Divergent transcription: a new feature of active promoters | Q37549811 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | breast cancer | Q128581 |
| estrogen | Q277954 | ||
| P304 | page(s) | 622-634 | |
| P577 | publication date | 2011-05-05 | |
| P1433 | published in | Cell | Q655814 |
| P1476 | title | A rapid, extensive, and transient transcriptional response to estrogen signaling in breast cancer cells | |
| P478 | volume | 145 |
| Q26859884 | "Seq-ing" insights into the epigenetics of neuronal gene regulation |
| Q90720395 | 17β-Estradiol Activates HSF1 via MAPK Signaling in ERα-Positive Breast Cancer Cells |
| Q92358694 | A CRISPR-Cas9 screen identifies essential CTCF anchor sites for estrogen receptor-driven breast cancer cell proliferation |
| Q39200778 | A Comprehensive Nuclear Receptor Network for Breast Cancer Cells |
| Q55222959 | A Multi-Parameter Analysis of Cellular Coordination of Major Transcriptome Regulation Mechanisms. |
| Q55357800 | A New Role for Estrogen Receptor α in Cell Proliferation and Cancer: Activating the Anticipatory Unfolded Protein Response. |
| Q38848709 | A Subset of Nuclear Receptors are Uniquely Expressed in Uveal Melanoma Cells |
| Q54118050 | A bi-stable feedback loop between GDNF, EGR1, and ERα contribute to endocrine resistant breast cancer |
| Q38695905 | A comprehensive comparison of tools for differential ChIP-seq analysis. |
| Q35159515 | A gene expression atlas of early craniofacial development |
| Q28673956 | A mammalian pseudogene lncRNA at the interface of inflammation and anti-inflammatory therapeutics |
| Q37327634 | A quality control system for profiles obtained by ChIP sequencing. |
| Q35116627 | A systematic in silico mining of the mechanistic implications and therapeutic potentials of estrogen receptor (ER)-α in breast cancer |
| Q50002288 | Alteration of Epigenetic Regulation by Long Noncoding RNAs in Cancer |
| Q41764330 | Alterations of androgen receptor-regulated enhancer RNAs (eRNAs) contribute to enzalutamide resistance in castration-resistant prostate cancer |
| Q33925069 | An Intrinsic Transcriptional Program Underlying Synaptic Scaling during Activity Suppression |
| Q40037734 | An annotation agnostic algorithm for detecting nascent RNA transcripts in GRO-seq |
| Q38099943 | An update on recent methods applied for deciphering the diversity of the noncoding RNA genome structure and function |
| Q64947122 | Analysis of Genetically Diverse Macrophages Reveals Local and Domain-wide Mechanisms that Control Transcription Factor Binding and Function. |
| Q39156237 | Androgen-responsive long noncoding RNA CTBP1-AS promotes prostate cancer |
| Q49832525 | Anti-estrogen therapy increases plasticity and cancer stemness of prolactin-induced ERα+ mammary carcinomas. |
| Q26796369 | Architectural and Functional Commonalities between Enhancers and Promoters |
| Q82725932 | Are ‘omics of Estrogen Receptors Defining Potential Targets for Breast Cancer Treatment? |
| Q90295002 | Ash2l interacts with Oct4-stemness circuitry to promote super-enhancer-driven pluripotency network |
| Q52430543 | Assessing sufficiency and necessity of enhancer activities for gene expression and the mechanisms of transcription activation. |
| Q26822737 | BRCA1 and estrogen/estrogen receptor in breast cancer: where they interact? |
| Q33886781 | Base-pair-resolution genome-wide mapping of active RNA polymerases using precision nuclear run-on (PRO-seq). |
| Q37341166 | Bioinformatics Analysis of Estrogen-Responsive Genes |
| Q34029386 | CBP Mediates NF-κB-Dependent Histone Acetylation and Estrogen Receptor Recruitment to an Estrogen Response Element in the BIRC3 Promoter |
| Q37507587 | CTCF modulates Estrogen Receptor function through specific chromatin and nuclear matrix interactions |
| Q39329169 | CTCF regulates NELF, DSIF and P-TEFb recruitment during transcription |
| Q91583760 | CXXC5 as an unmethylated CpG dinucleotide binding protein contributes to estrogen-mediated cellular proliferation |
| Q49566680 | Cancer transcriptome profiling at the juncture of clinical translation |
| Q50207620 | Catalytic-Independent Functions of PARP-1 Determine Sox2 Pioneer Activity at Intractable Genomic Loci |
| Q49163645 | Cdk9 regulates a promoter-proximal checkpoint to modulate RNA polymerase II elongation rate in fission yeast. |
| Q33854262 | Cell cycle dependent oscillatory expression of estrogen receptor-α links Pol II elongation to neoplastic transformation |
| Q39140799 | Cell‐specific integration of nuclear receptor function at the genome |
| Q89606574 | Characterization of basal and estrogen-regulated antisense transcription in breast cancer cells: Role in regulating sense transcription |
| Q88718519 | Characterization of noncoding regulatory DNA in the human genome |
| Q38793084 | Chromatin remodeling effects on enhancer activity |
| Q28727255 | Cistrome plasticity and mechanisms of cistrome reprogramming |
| Q37270352 | Co-transcriptional R-loops are the main cause of estrogen-induced DNA damage |
| Q30597594 | Comparative annotation of functional regions in the human genome using epigenomic data |
| Q31132786 | Computational Approaches for Mining GRO-Seq Data to Identify and Characterize Active Enhancers |
| Q36144746 | Computational inference of mRNA stability from histone modification and transcriptome profiles |
| Q38471565 | Corticosteroid receptor signalling modes and stress adaptation in the brain |
| Q35458646 | Coupled pre-mRNA and mRNA dynamics unveil operational strategies underlying transcriptional responses to stimuli. |
| Q47699717 | DNA Sequence Constraints Define Functionally Active Steroid Nuclear Receptor Binding Sites in Chromatin |
| Q47148323 | Defining the location of promoter-associated R-loops at near-nucleotide resolution using bisDRIP-seq. |
| Q36021732 | Differential DNase I hypersensitivity reveals factor-dependent chromatin dynamics |
| Q90774019 | Discovering Transcriptional Regulatory Elements From Run-On and Sequencing Data Using the Web-Based dREG Gateway |
| Q37972237 | Discovering genome regulation with 3C and 3C-related technologies |
| Q34074703 | Discovering transcription factor regulatory targets using gene expression and binding data |
| Q35987511 | Discovery, Annotation, and Functional Analysis of Long Noncoding RNAs Controlling Cell-Cycle Gene Expression and Proliferation in Breast Cancer Cells |
| Q64101595 | Displacement of WDR5 from Chromatin by a WIN Site Inhibitor with Picomolar Affinity |
| Q90260424 | Distinct Roles for BET Family Members in Estrogen Receptor α Enhancer Function and Gene Regulation in Breast Cancer Cells |
| Q47831235 | Dynamic assembly and activation of estrogen receptor α enhancers through coregulator switching. |
| Q30580514 | Dynamic estrogen receptor interactomes control estrogen-responsive trefoil Factor (TFF) locus cell-specific activities |
| Q54963126 | Dynamic evolution of regulatory element ensembles in primate CD4+ T cells. |
| Q35068557 | Dynamic regulation of transcriptional states by chromatin and transcription factors. |
| Q35101212 | Dynamic reorganization of the AC16 cardiomyocyte transcriptome in response to TNFα signaling revealed by integrated genomic analyses |
| Q42050873 | Dynamic reprogramming of chromatin: paradigmatic palimpsests and HES factors |
| Q42256986 | Dynamic transitions in RNA polymerase II density profiles during transcription termination |
| Q37372273 | Dynamics of Protein Expression Reveals Primary Targets and Secondary Messengers of Estrogen Receptor Alpha Signaling in MCF-7 Breast Cancer Cells |
| Q53699376 | ER-positive breast cancer cells are poised for RET-mediated endocrine resistance. |
| Q90001324 | ESR1-Stabilizing Long Noncoding RNA TMPO-AS1 Promotes Hormone-Refractory Breast Cancer Progression |
| Q49529316 | Emerging Roles of Transcriptional Enhancers In Chromatin Looping And Promoter-Proximal Pausing Of RNA Polymerase II. |
| Q27002577 | Emerging epigenetic mechanisms of long non-coding RNAs |
| Q34292008 | Enhancer RNA facilitates NELF release from immediate early genes |
| Q36569927 | Enhancer RNA-driven looping enhances the transcription of the long noncoding RNA DHRS4-AS1, a controller of the DHRS4 gene cluster |
| Q26865277 | Enhancer RNAs and regulated transcriptional programs |
| Q96230995 | Enhancer RNAs are an important regulatory layer of the epigenome |
| Q90058002 | Enhancer occlusion transcripts regulate the activity of human enhancer domains via transcriptional interference: a computational perspective |
| Q95328259 | Enhancer reprogramming driven by high-order assemblies of transcription factors promotes phenotypic plasticity and breast cancer endocrine resistance |
| Q49607235 | Enhancer transcription reveals subtype-specific gene expression programs controlling breast cancer pathogenesis. |
| Q42597586 | Enhancer transcripts mark active estrogen receptor binding sites |
| Q42733506 | Enhancer-derived RNAs: ‘spicing up’ transcription programs |
| Q34046402 | Enhancers as non-coding RNA transcription units: recent insights and future perspectives |
| Q64065013 | Epigenetic and transcriptional profiling of triple negative breast cancer |
| Q47142116 | Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone |
| Q24273294 | Epigenetic pathways and glioblastoma treatment |
| Q38118486 | Epigenomic control of the innate immune response |
| Q34372573 | Epigenomics of macrophages |
| Q42116309 | Estradiol-Estrogen Receptor α Mediates the Expression of the CXXC5 Gene through the Estrogen Response Element-Dependent Signaling Pathway |
| Q39444073 | Estradiol-activated estrogen receptor α does not regulate mature microRNAs in T47D breast cancer cells |
| Q35970128 | Estrogen Regulates JNK1 Genomic Localization to Control Gene Expression and Cell Growth in Breast Cancer Cells |
| Q51015387 | Estrogen receptor alpha: molecular mechanisms and emerging insights |
| Q35585091 | Estrogen receptor beta impacts hormone-induced alternative mRNA splicing in breast cancer cells |
| Q37094009 | Estrogen receptor splice variants as a potential source of false-positive estrogen receptor status in breast cancer diagnostics |
| Q37392880 | Estrogen regulates miRNA expression: implication of estrogen receptor and miR-124/AKT2 in tumor growth and angiogenesis |
| Q37197796 | Estrogen represses gene expression through reconfiguring chromatin structures |
| Q34712579 | Estrogen-dependent dynamic profile of eNOS-DNA associations in prostate cancer |
| Q92595732 | Estrogen-induced transcription at individual alleles is independent of receptor level and active conformation but can be modulated by coactivators activity |
| Q38365224 | Eukaryotic enhancers: common features, regulation, and participation in diseases |
| Q29615949 | Extensive Promoter-Centered Chromatin Interactions Provide a Topological Basis for Transcription Regulation |
| Q36902919 | Extensive polymerase pausing during Drosophila axis patterning enables high-level and pliable transcription |
| Q55266290 | FOCS: a novel method for analyzing enhancer and gene activity patterns infers an extensive enhancer-promoter map. |
| Q35024083 | From discovery to function: the expanding roles of long noncoding RNAs in physiology and disease |
| Q39395490 | Functional characterization of a human cyclin T1 mutant reveals a different binding surface for Tat and HEXIM1. |
| Q92560311 | Functional impacts of non-coding RNA processing on enhancer activity and target gene expression |
| Q34348069 | Functional roles of enhancer RNAs for oestrogen-dependent transcriptional activation |
| Q39240915 | GATA3 acts upstream of FOXA1 in mediating ESR1 binding by shaping enhancer accessibility |
| Q36199553 | GC skew defines distinct RNA polymerase pause sites in CpG island promoters |
| Q38456475 | Genome-wide ChIP-seq analysis of human TOP2B occupancy in MCF7 breast cancer epithelial cells |
| Q37687555 | Genome-wide activity of unliganded estrogen receptor-α in breast cancer cells. |
| Q90070094 | Genome-wide analysis and functional prediction of the estrogen-regulated transcriptional response in the mouse uterus† |
| Q36233379 | Genome-wide assessment of sequence-intrinsic enhancer responsiveness at single-base-pair resolution |
| Q37970952 | Genome-wide expression of non-coding RNA and global chromatin modification |
| Q92424009 | Genome-wide interaction target profiling reveals a novel Peblr20-eRNA activation pathway to control stem cell pluripotency |
| Q41191763 | Genomewide Analysis of Clp1 Function in Transcription in Budding Yeast |
| Q33659512 | Global analysis of p53-regulated transcription identifies its direct targets and unexpected regulatory mechanisms. |
| Q39376859 | Global analysis of transcription in castration-resistant prostate cancer cells uncovers active enhancers and direct androgen receptor targets. |
| Q47146098 | Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate |
| Q91683266 | HACER: an atlas of human active enhancers to interpret regulatory variants |
| Q27321618 | Highly sensitive quantitative imaging for monitoring single cancer cell growth kinetics and drug response |
| Q37351081 | Hormone-regulated transcriptomes: lessons learned from estrogen signaling pathways in breast cancer cells |
| Q34310275 | How to stop: the mysterious links among RNA polymerase II occupancy 3' of genes, mRNA 3' processing and termination |
| Q30914286 | Identification of active transcriptional regulatory elements from GRO-seq data |
| Q36063718 | Identification of estrogen-responsive genes based on the DNA binding properties of estrogen receptors using high-throughput sequencing technology |
| Q90679707 | Identification of regulatory elements from nascent transcription using dREG |
| Q58092059 | Identifying deer antler uhrf1 proliferation and s100a10 mineralization genes using comparative RNA-seq |
| Q36634127 | Illuminating microRNA Transcription from the Epigenome |
| Q35843046 | Induction of proto-oncogene BRF2 in breast cancer cells by the dietary soybean isoflavone daidzein |
| Q30821202 | Inference of RNA polymerase II transcription dynamics from chromatin immunoprecipitation time course data |
| Q35031399 | Inflammation-sensitive super enhancers form domains of coordinately regulated enhancer RNAs |
| Q33787422 | Insights from Global Analyses of Long Noncoding RNAs in Breast Cancer |
| Q36228477 | Integrated genome analysis suggests that most conserved non-coding sequences are regulatory factor binding sites |
| Q34493813 | Integrating multiple oestrogen receptor alpha ChIP studies: overlap with disease susceptibility regions, DNase I hypersensitivity peaks and gene expression |
| Q30652671 | Integrative analysis of deep sequencing data identifies estrogen receptor early response genes and links ATAD3B to poor survival in breast cancer |
| Q37660496 | Integrative genomics of gene and metabolic regulation by estrogen receptors α and β, and their coregulators |
| Q36479035 | Integrator mediates the biogenesis of enhancer RNAs. |
| Q38789346 | Interplay between steroid hormone activation of the unfolded protein response and nuclear receptor action. |
| Q37591520 | Interplay of chromatin modifications and non-coding RNAs in the heart |
| Q90567475 | Intrinsic Dynamics of a Human Gene Reveal the Basis of Expression Heterogeneity |
| Q52328749 | JMJD6 Licenses ERα-Dependent Enhancer and Coding Gene Activation by Modulating the Recruitment of the CARM1/MED12 Co-activator Complex. |
| Q34069945 | Kinesin family deregulation coordinated by bromodomain protein ANCCA and histone methyltransferase MLL for breast cancer cell growth, survival, and tamoxifen resistance |
| Q34411315 | Kinetic competition during the transcription cycle results in stochastic RNA processing |
| Q28255964 | LAS1L interacts with the mammalian Rix1 complex to regulate ribosome biogenesis |
| Q34275017 | Large-scale functional organization of long-range chromatin interaction networks |
| Q92438534 | Ligand dependent gene regulation by transient ERα clustered enhancers |
| Q52804324 | Long ncRNA A-ROD activates its target gene DKK1 at its release from chromatin. |
| Q38148964 | Long non-coding RNA-guided regulation in organisms |
| Q26827949 | Long non-coding RNAs as regulators of the endocrine system |
| Q37589709 | Long non-coding RNAs: modulators of nuclear structure and function |
| Q37528915 | Long-range regulators of the lncRNA HOTAIR enhance its prognostic potential in breast cancer |
| Q38053130 | Long‐range transcriptional regulation of breast cancer genes |
| Q49805024 | Luminal lncRNAs Regulation by ERα-Controlled Enhancers in a Ligand-Independent Manner in Breast Cancer Cells |
| Q36772092 | Luminal long non-coding RNAs regulated by estrogen receptor alpha in a ligand-independent manner show functional roles in breast cancer |
| Q34949372 | Mapping ERβ Genomic Binding Sites Reveals Unique Genomic Features and Identifies EBF1 as an ERβ Interactor |
| Q27006789 | Mechanisms Underlying the Selection and Function of Macrophage-Specific Enhancers |
| Q26765380 | Mechanisms of oestrogen receptor (ER) gene regulation in breast cancer |
| Q34005895 | Meta-analysis of estrogen response in MCF-7 distinguishes early target genes involved in signaling and cell proliferation from later target genes involved in cell cycle and DNA repair |
| Q64245167 | Metabolic Reprogramming in Breast Cancer and Its Therapeutic Implications |
| Q91728021 | MicroRNA-196a is regulated by ER and is a prognostic biomarker in ER+ breast cancer |
| Q36279521 | Minireview: Applications of Next-Generation Sequencing on Studies of Nuclear Receptor Regulation and Function |
| Q27016106 | Minireview: Inflammation: An Instigator of More Aggressive Estrogen Receptor (ER) Positive Breast Cancers |
| Q27011299 | Minireview: Long Noncoding RNAs: New “Links” Between Gene Expression and Cellular Outcomes in Endocrinology |
| Q36113793 | Minireview: The androgen receptor in breast tissues: growth inhibitor, tumor suppressor, oncogene? |
| Q26775145 | Minor Loops in Major Folds: Enhancer-Promoter Looping, Chromatin Restructuring, and Their Association with Transcriptional Regulation and Disease |
| Q42367753 | Mutant p53 shapes the enhancer landscape of cancer cells in response to chronic immune signaling. |
| Q92535255 | Nascent RNA analyses: tracking transcription and its regulation |
| Q58713866 | Nascent RNA sequencing analysis provides insights into enhancer-mediated gene regulation |
| Q47808404 | Nascent RNA sequencing reveals a dynamic global transcriptional response at genes and enhancers to the natural medicinal compound celastrol. |
| Q90099983 | Nascent transcript analysis of glucocorticoid crosstalk with TNF defines primary and cooperative inflammatory repression |
| Q36797315 | Noncoding RNAs Involved in Mammary Gland Development and Tumorigenesis: There’s a Long Way to Go |
| Q38845436 | Noncoding RNAs in Growth and Death of Cancer Cells |
| Q33610918 | Novel roles for ERK5 and cofilin as critical mediators linking ERα-driven transcription, actin reorganization, and invasiveness in breast cancer |
| Q26821789 | Nuclear Receptors, RXR, and the Big Bang |
| Q37277897 | Oestrogen receptors in breast cancer: basic mechanisms and clinical implications. |
| Q38027950 | Oestrogen-dependent regulation of miRNA biogenesis: many ways to skin the cat |
| Q28572838 | Olig2 Targets Chromatin Remodelers to Enhancers to Initiate Oligodendrocyte Differentiation |
| Q28115180 | PA1 Protein, a New Competitive Decelerator Acting at More than One Step to Impede Glucocorticoid Receptor-mediated Transactivation |
| Q24294591 | Peptidylarginine deiminase 2-catalyzed histone H3 arginine 26 citrullination facilitates estrogen receptor α target gene activation |
| Q92129348 | Phase separation of ligand-activated enhancers licenses cooperative chromosomal enhancer assembly |
| Q34272580 | Pioneer factors in hormone-dependent cancers |
| Q33631279 | Pol II docking and pausing at growth and stress genes in C. elegans |
| Q38606913 | Precise Maps of RNA Polymerase Reveal How Promoters Direct Initiation and Pausing |
| Q42368570 | Predicting stimulation-dependent enhancer-promoter interactions from ChIP-Seq time course data |
| Q35856448 | Pregnancy and estrogen enhance neural progenitor-cell proliferation in the vomeronasal sensory epithelium. |
| Q64882504 | Production of Spliced Long Noncoding RNAs Specifies Regions with Increased Enhancer Activity. |
| Q64094448 | Prognostic role of Tif1γ expression and circulating tumor cells in patients with breast cancer |
| Q38275663 | Promoter or enhancer, what's the difference? Deconstruction of established distinctions and presentation of a unifying model. |
| Q35658687 | Promoter-Autonomous Functioning in a Controlled Environment using Single Molecule FISH. |
| Q36904381 | Promoter-proximal CCCTC-factor binding is associated with an increase in the transcriptional pausing index |
| Q92254256 | Promoter-proximal pausing of RNA polymerase II: a nexus of gene regulation |
| Q38852230 | Quantification of nascent transcription by bromouridine immunocapture nuclear run-on RT-qPCR. |
| Q38721439 | RNA Binding to CBP Stimulates Histone Acetylation and Transcription |
| Q31090090 | RNA Pol II transcription model and interpretation of GRO-seq data |
| Q34960186 | RNA Polymerase II Transcription Elongation Control |
| Q64118484 | RNA Stabilizes Transcription-Dependent Chromatin Loops Induced By Nuclear Hormones |
| Q36505626 | RNA polymerase II pausing as a context-dependent reader of the genome |
| Q35562114 | RNA polymerase II pausing can be retained or acquired during activation of genes involved in the epithelial to mesenchymal transition. |
| Q34305741 | RNA polymerase II pausing downstream of core histone genes is different from genes producing polyadenylated transcripts |
| Q37523925 | RNA-seq differential expression studies: more sequence or more replication? |
| Q38562823 | Ready, pause, go: regulation of RNA polymerase II pausing and release by cellular signaling pathways |
| Q47697599 | Real-Time Imaging of a Single Gene Reveals Transcription-Initiated Local Confinement. |
| Q51415993 | Real-time Analysis of Transcription Factor Binding, Transcription, Translation, and Turnover to Display Global Events During Cellular Activation |
| Q38701309 | Recognition of long-range enhancer-promoter interactions by adding genomic signatures of segmented regulatory regions |
| Q35945067 | Regulating the regulators: the pervasive effects of Pol II pausing on stimulus-responsive gene networks |
| Q38555446 | Regulation of Glucose Homeostasis by Glucocorticoids |
| Q26775423 | Regulation of MYC gene expression by aberrant Wnt/β-catenin signaling in colorectal cancer |
| Q35540172 | Regulation of Primary Response Genes |
| Q27011533 | Regulation of mammary epithelial cell homeostasis by lncRNAs |
| Q24317494 | Regulation of transcription through acetylation of H3K122 on the lateral surface of the histone octamer |
| Q42972194 | Remodeling of the enhancer landscape during macrophage activation is coupled to enhancer transcription. |
| Q89813344 | Ret Receptor Has Distinct Alterations and Functions in Breast Cancer |
| Q37340291 | Rev-Erbs repress macrophage gene expression by inhibiting enhancer-directed transcription. |
| Q36427075 | Sex differences in microRNA regulation of gene expression: no smoke, just miRs |
| Q38429827 | Sex differences in microRNA-mRNA networks: examination of novel epigenetic programming mechanisms in the sexually dimorphic neonatal hypothalamus |
| Q37524578 | Sex differences in the human peripheral blood transcriptome |
| Q48184878 | Signaling by Steroid Hormones in the 3D Nuclear Space. |
| Q40264121 | Signaling pathways differentially affect RNA polymerase II initiation, pausing, and elongation rate in cells |
| Q35795043 | Single-Molecule Sequencing Reveals Estrogen-Regulated Clinically Relevant lncRNAs in Breast Cancer. |
| Q42291804 | Single-cell profiling reveals that eRNA accumulation at enhancer-promoter loops is not required to sustain transcription |
| Q51542428 | Single-tube linear DNA amplification for genome-wide studies using a few thousand cells. |
| Q58093155 | Statistical inference of the rate of RNA polymerase II elongation by total RNA sequencing |
| Q26865967 | Steering tumor progression through the transcriptional response to growth factors and stroma |
| Q37624907 | Support of a bi-faceted role of estrogen receptor β (ERβ) in ERα-positive breast cancer cells |
| Q38503197 | TADs as modular and dynamic units for gene regulation by hormones |
| Q35269181 | TNFα signaling exposes latent estrogen receptor binding sites to alter the breast cancer cell transcriptome |
| Q37009455 | Targeted RNA sequencing reveals the deep complexity of the human transcriptome |
| Q64102425 | The CDK7 inhibitor THZ1 alters RNA polymerase dynamics at the 5' and 3' ends of genes |
| Q36019938 | The Commercial Antibodies Widely Used to Measure H3 K56 Acetylation Are Non-Specific in Human and Drosophila Cells. |
| Q52366978 | The IL-4/STAT6/PPARγ signaling axis is driving the expansion of the RXR heterodimer cistrome, providing complex ligand responsiveness in macrophages. |
| Q52532552 | The INO80 remodeller in transcription, replication and repair |
| Q92761313 | The IncRNA BORG: A novel inducer of TNBC metastasis, chemoresistance, and disease recurrence |
| Q28086829 | The Landscape of long noncoding RNA classification |
| Q38885465 | The Working Modules of Long Noncoding RNAs in Cancer Cells |
| Q33917441 | The active enhancer network operated by liganded RXR supports angiogenic activity in macrophages. |
| Q38915010 | The bright side of dark matter: lncRNAs in cancer |
| Q93192968 | The enhancer RNA lnc-SLC4A1-1 epigenetically regulates unexplained recurrent pregnancy loss (URPL) by activating CXCL8 and NF-kB pathway |
| Q26767112 | The first decade of estrogen receptor cistromics in breast cancer |
| Q38934752 | The histone variant H2A.Z is an important regulator of enhancer activity |
| Q35191305 | The intriguing complexities of mammalian gene regulation: how to link enhancers to regulated genes. Are we there yet? |
| Q37315073 | The lncRNA landscape of breast cancer reveals a role for DSCAM-AS1 in breast cancer progression |
| Q35597074 | The long noncoding RNAs NEAT1 and MALAT1 bind active chromatin sites |
| Q90591670 | Three-dimensional chromatin landscapes in T cell acute lymphoblastic leukemia |
| Q97519052 | Total Functional Score of Enhancer Elements Identifies Lineage-Specific Enhancers That Drive Differentiation of Pancreatic Cells |
| Q36118451 | Transcript dynamics of proinflammatory genes revealed by sequence analysis of subcellular RNA fractions |
| Q91610618 | Transcriptional control by enhancers and enhancer RNAs |
| Q36902905 | Transcriptional elongation checkpoint control in development and disease |
| Q38194866 | Transcriptional enhancers: from properties to genome-wide predictions |
| Q41678024 | Transcriptional landscape of the human cell cycle. |
| Q30763243 | Transcriptional regulation prediction of antiestrogen resistance in breast cancer based on RNA polymerase II binding data |
| Q46250979 | Transcriptome profiling analysis of senescent gingival fibroblasts in response to Fusobacterium nucleatum infection |
| Q34131693 | Transient estrogen receptor binding and p300 redistribution support a squelching mechanism for estradiol-repressed genes |
| Q33945643 | UVB induces a genome-wide acting negative regulatory mechanism that operates at the level of transcription initiation in human cells |
| Q35989796 | Ups and Downs of Poised RNA Polymerase II in B-Cells |
| Q37606961 | Vespucci: a system for building annotated databases of nascent transcripts |
| Q30980309 | groHMM: a computational tool for identifying unannotated and cell type-specific transcription units from global run-on sequencing data |
| Q30883063 | iRNA-seq: computational method for genome-wide assessment of acute transcriptional regulation from total RNA-seq data |
| Q38375432 | lncRNA and gene looping: what's the connection? |
| Q37316805 | miRNA clusters as therapeutic targets for hormone-resistant breast cancer |
| Q35946984 | miRNAs and estrogen action |
| Q35912303 | miRNAs regulated by estrogens, tamoxifen, and endocrine disruptors and their downstream gene targets. |
Search more.